Administration of COVID-19 vaccines in immunocompromised patients - ScienceDirectTransplantationCancerMultiple sclerosisInflammatory bowel diseaseVaccinationHematologic malignanciesSince the beginning of vaccination programs against COVID-19 in different countries, several populations such as patients with specific ...
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis Background:Immunocompromised (IC) patients are at higher risk of severe SARS-CoV-2 infection, morbidity, and mortality compared to the general population. ... MMM Nejad,F Moosaie,H Dehghan...
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study Chiara Bellitto Nicoletta Luxi Gianluca Trifirò Drug Safety (2024) Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-...
Disadvantages associated with live attenuated vaccines include the challenges associated with long-term storage and transport as well as the potential for a patient to develop signs and symptoms of disease during the active infection (particularly in immunocompromised patients). There is also a risk of...
three doses of a recombinant subunit zoster vaccine93and four doses of an inactivated herpes zoster vaccine85,94,95lead to high seropositivity rates and acceptable levels of protection. This experience supports the idea that patients who are either immunocompromised or immunosuppressed might require mo...
Cross-reactivity to other species was observed suggesting this could be part of a broad approach towards therapeutic vaccination in immunocompromised patients with mold infections68. Another novel approach worthy of mention, although not technically a therapeutic vaccine, is the use of chimeric antigen ...
These authorities also state that it may be appropriate to consider periodic re-vaccination of certain high-risk immunocompromised patients, who are likely to have poor initial antibody response and rapid decline of antibodies after vaccination. In addition, re-vaccination with the 23-valent ...
Exposure of immunocompromised children to varicella often requires postexposure prophylaxis. Exposures requiring this management are often not recognized. ... MJ Levin - 《Journal of Infectious Diseases》 被引量: 69发表: 2008年 Varicella: To vaccinate or not to vaccinate? "Improbability of effective ...
Overall, our results confirm the concept that in immunocompromised patients the third vaccine dose is not a booster dose, but it is a necessary completion of a regular vaccination cycle. Indeed, the significant decline of the antibody titer after 6 months from the second dose and the incomplete...
Although the adjuvanted and nonadjuvanted RSV vaccines have not been studied in immunocompromised patients, theoretically they could provide benefits to this high-risk population.18-20 Both vaccines are inactivated and so are anticipated to be safe for these patients. Logistical Considerations The logisti...